Chapter 14A Flashcards
Neuropharmacology
The study of how drugs affect the function of the CNS
When an action potential reaches the pre-synaptic nerve terminal it causes influx of __
Calcium
Which then causes vesicles with neurotransmitter to fuse to membrane
What are the classes of neurotransmitters?
Monoamines
Amino acids
Other
Examples of monoamine neurotransmitters:
Norepinephrine
Epinephrine
Dopamine
Serotonin
Examples of amino acid neurotransmitters:
Excitatory - glutamate and aspartate
Inhibitory - GABA and glycine
Example of other neurotransmitters:
acetylcholine
What are the 5 different basic mechanisms of CNS drugs:
1) Replacement
2) Agonist/antagonist
3) Inhibiting neurotransmitter breakdown
4) Blocking reuptake
5) Nerve stimulation
Describe Parkinson’s Disease
Discovered by James Parkinson in 1817
Progressive loss of dopaminergic neurons in substantia nigra (70-80%)
Without treatment - in 5-10 years patient cannot care for themselves
Chronic movement disorder caused by too much acetylcholine and too little dopamine
Symptoms of Parkinson’s
1) Tremor (extremities)
2) Rigidity (joint stiffness and increased muscle tone)
3) Bradykinesia (initiating movements)
4) Masklike face (difficulty blinking and swallowing)
5) Postural instability
6) Dementia
Symptoms of Parkinson’r arise because of what three things:
1) Decrease dopamine - not enough to inhibit GABA release
2) Relative excess of acetylcholine - activates GABA release
3) Excess GABA causes the movement disorders
Is the etiology of Parkinson’s largely known or unknown? What is thought to be caused by?
unknown
1) Street drugs that have MPTP
2) Genetics - mutation in 4 genes (alpha synuclein, parkin, UCHL1, DJ1)
3) Environmental toxins
4) Brain trauma
5) Oxidative stress
What are the 5 major classes of drugs used to treat Parkinson’s?
1) Dopamine replacement - L-dopa
2) Dopamine agonist
3) Dopamine releaser
4) Catecholamine-O-methyltransferase inhibitor
5) Monoamine oxidaseB inhibitor
What is Levodopa and what does it do?
Most effective drug for treating PD (benefits decrease over time)
Crosses blood brain barrier by active transport protein and is inactive until converted to dopamine in dopaminergic nerve terminals
This conversion is mediated by decarboxylase enzymes in the brain
Cofactor pyridoxine (vitamin B6) speeds up this reaction
Why can we not just give someone with PD dopamine?
Because it cannot cross the BBB and has a very short half-life in the blood
Side effects of L-DOPA:
Nausea and vomiting Dyskinesias Cardiac dysrhythmias - conversion to dopamine in periphery can result in activation of cardiac beta 1 receptors Orthostatic hypotension Psychosis
Peripheral Metabolism of L-DOPA
Only 1% of LDOPA reaches the brain
Almost always given with carbidopa (decarboxylase inhibitor) so that 10% reaches the brain
It also decreases cardiac dysrhythmias, nausea and vomiting
What are the two types of loss of effect that patients taking LDOPA might experience?
- Wearing off (gradual)
2. On-off (abrupt loss of effect)
What is we wearing off? How can it be minimized?
Occurs at end of dosing interval and indicates drug levels might be low
Minimized by:
- shorter dosing interval
- drug that inhibits LDOPA metabolism (e.g COMT)
- add dopamine agonist
What is On-off loss of effect? How can it be minimized?
Can occur when drug levels are high
Minimized by:
- divide medication into 3-6 doses/day
- use controlled release formulation
- move protein containing meals to evening
What do dopamine agonists do?
Produce effects by directly activating dopamine receptors on post-synaptic membrane
Not as effective as LDOPA (for patients with milder conditions)
Adverse effects of dopamine agonists:
Hallucinations
Daytime drowsiness
Orthostatic hypotension
What do dopamine releasers do?
Stimulate release of dopamine from dopaminergic neurons and also blocks dopamine reuptake
Adverse effects of dopamine releaser:
Dizziness, nausea, vomiting, lethargy, and anticholinergic side effects
What do catecholamine-o-methyltransferase (COMT) inhibitors do?
Enzyme that adds methyl group to both dopamine and LDOPA
When methylated they are inactive
Inhibiting COMT results in greater fraction of LDOPA that is available to become dopamine
Only moderately effective
Adverse effects of COMT inhibitors:
Nausea
Orthostatic hypotension
Vivid dreams
Hallucinations
What do monoamine oxidaseB (MAO-B) Inhibitors do?
Enzyme that oxidatively metabolizes dopamine and LDOPA - inactivating them
Inhibiting metabolism allows more conversion to dopamine in the brain and remain in nerve terminals
Only moderately effective